{
    "table_id": "finqa_a0e69e9aee",
    "source": "finqa",
    "original_metadata": {
        "source_dataset": "finqa",
        "document_id": "GPN/2013/page_98.pdf-2",
        "pre_text_caption_evidence": [
            "item 11 2014executive compensation we incorporate by reference in this item 11 the information relating to executive and director compensation contained under the headings 201cother information about the board and its committees , 201d 201ccompensation and other benefits 201d and 201creport of the compensation committee 201d from our proxy statement to be delivered in connection with our 2013 annual meeting of shareholders to be held on november 20 , 2013 .",
            "item 12 2014security ownership of certain beneficial owners and management and related stockholder matters we incorporate by reference in this item 12 the information relating to ownership of our common stock by certain persons contained under the headings 201ccommon stock ownership of management 201d and 201ccommon stock ownership by certain other persons 201d from our proxy statement to be delivered in connection with our 2013 annual meeting of shareholders to be held on november 20 , 2013 .",
            "the following table provides certain information as of may 31 , 2013 concerning the shares of the company 2019s common stock that may be issued under existing equity compensation plans .",
            "for more information on these plans , see note 11 to notes to consolidated financial statements .",
            "plan category number of securities to be issued upon exercise of outstanding options , warrants and rights weighted- average exercise price of outstanding options , warrants and rights number of securities remaining available for future issuance under equity compensation plans ( excluding securities reflected in column ( a ) ) equity compensation plans approved by security holders : 1765510 $ 34.92 7927210 ( 1 ) equity compensation plans not approved by security holders : 2014 2014 2014 ."
        ],
        "question": "if the company were to buy the remaining securities at the average price of $ 34.92 , what would be the total payments from the company?"
    },
    "dimensions": {
        "rows": 3,
        "columns": 5
    },
    "schema": {
        "columns": [
            "plan category",
            "number of securities to be issued upon exercise of outstanding options warrants and rights ( a )",
            "weighted-average exerciseprice of outstanding options warrants and rights ( b )",
            "number of securitiesremaining available forfuture issuance under equity compensation plans ( excluding securities reflected in column ( a ) ) ( c )",
            ""
        ],
        "dtypes": {
            "plan category": "object",
            "number of securities to be issued upon exercise of outstanding options warrants and rights ( a )": "object",
            "weighted-average exerciseprice of outstanding options warrants and rights ( b )": "object",
            "number of securitiesremaining available forfuture issuance under equity compensation plans ( excluding securities reflected in column ( a ) ) ( c )": "object",
            "": "object"
        }
    }
}